Skip to main content

Nonprofit · EIN 83-2388861

GLIOBLASTOMA RESEARCH ORGANIZATION INC

Tax-exempt · MIAMI, FL 33137

Financials

$832K$480K2023$1M$808K2024$1.8M$1.1M2025
Revenue Expenses · by fiscal year end
Financials of GLIOBLASTOMA RESEARCH ORGANIZATION INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$1,804,767$1,112,732$692,035$1,432,059$36,353$1,395,706
December 31, 2024990$1,025,244$807,776$217,468$728,675$25,004$703,671
December 31, 2023990$832,005$480,261$351,744$492,941$6,738$486,203
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$1,775,406
Program service revenue
$0
Investment income
$29,361
Other revenue
$0

Expenses

Grants and similar amounts paid
$189,316
Compensation of officers, directors and key employees
$127,693
Other salaries and wages
$115,111
Salaries, compensation and benefits (total)
$262,171
Professional fundraising fees
$0
Legal fees
$23,749
Accounting fees
$46,293
Travel
$46,776
Depreciation
$601
Program services (functional)
$874,610
Management and general (functional)
$101,982
Fundraising (functional)
$136,140

Balance sheet and other

Total assets, start of year
$728,675
Total assets, end of year
$1,432,059
Total liabilities, end of year
$36,353
Net assets, end of year
$1,395,706
Land, buildings and equipment
$3,030
Net assets without donor restrictions
$1,395,706
Gross receipts
$1,804,767
Employees
4
Volunteers
35
Year formed
2018
State of legal domicile
NY

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
AMBER BARBACHFOUNDER AND EXECUTIVE DIRECTOR
Trustee or director, Officer
40$108,429
AZUL M DIEZDEVELOPMENT DIRECTOR
Highest-paid employee
40$104,792
ELISSA BARBACHVICE PRESIDENT
Trustee or director, Officer
20$19,264
KYLIE BARNESSECRETARY
Trustee or director, Officer
1$0
MARVIN LEWDIRECTOR
Trustee or director
10$0
YONATAN BARDASHDIRECTOR
Trustee or director
1$0
990 for the year ended December 31, 2024: 6 people
NameTitleHours / weekCompensationOther / benefits
AMBER BARBACHFOUNDER AND EXECUTIVE DIRECTOR
Trustee or director, Officer
60$105,237$512
KATHERINE SNEDEKERDIRECTOR
Trustee or director
10$20,000$0
ELISSA BARBACHVICE PRESIDENT
Trustee or director, Officer
20$11,638$0
KYLIE BARNESSECRETARY
Trustee or director, Officer
1$0$0
MARVIN LEWDIRECTOR
Trustee or director
10$0$0
YONATAN BARDASHDIRECTOR
Trustee or director
1$0$0
990 for the year ended December 31, 2023: 6 people
NameTitleHours / weekCompensationOther / benefits
AMBER BARBACHFOUNDER AND EXECUTIVE DIRECTOR
Trustee or director, Officer
75$70,962$5,050
KATHERINE SNEDEKERDIRECTOR
Trustee or director
1$22,885$0
ELISSA BARBACHVICE PRESIDENT
Trustee or director, Officer
20$8,000$0
KYLIE BARNESSECRETARY
Trustee or director, Officer
1$0$0
MARVIN LEWDIRECTOR
Trustee or director
10$0$0
YONATAN BARDASHDIRECTOR
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
2045 BISCAYNE BLVD, MIAMI, FL 33137-5025
Principal officer (990 for 2025)
AMBER BARBACH, 2045 BISCAYNE BLVD 189, MIAMI, FL 33137
Signed the 990
AMBER BARBACH, FOUNDER AND EXECUTIVE DIRECTOR
Phone
(305) 984-8164
Return prepared by
AAFCPAS INC

Mission

GLIOBLASTOMA RESEARCH ORGANIZATION, INC. IS A 501(C)(3) NONPROFIT ORGANIZATION THAT RAISES AWARENESS AND FUNDS FOR NEW GLOBAL, CUTTING-EDGE RESEARCH TO HELP FIND A CURE FOR GLIOBLASTOMA.

990 for the year ended December 31, 2025

Program accomplishments

  • SEE SCHEDULE O FOR DETAIL.THE ORGANIZATION TO DATE, HAS PROVIDED SUPPORT TO DOCTORS AND RESEARCHERS THROUGH SIXTEEN FULLY FUNDED PROJECTS AT LEADING CANCER CENTERS. THE ORGANIZATION ALSO DONATED OVER $675,000 IN THE LAST FEW YEARS AND HAS PARTNERED WITH GBM-RELATED PROJECTS AROUND THE GLOBE. THE ORGANIZATION HAS THE OPPORTUNITY TO MEET WITH LEADERS IN NEURO-ONCOLOGY AS WELL AS CONNECT WITH THE PEOPLE AND FAMILIES DIRECTLY IMPACTED BY GLIOBLASTOMA. THE STORIES BEHIND THIS DEADLY CANCER DRIVE OUR RESEARCH FUNDING MISSION. FUELED BY OUR FOUNDER'S PERSONAL EXPERIENCE WITH GBM, THE GLIOBLASTOMA RESEARCH ORGANIZATION'S COMMUNICATIONS CHANNELS, SUCH AS SOCIAL MEDIA, SERVE AS A BRIDGE TO CONNECT THOSE ALL OVER THE WORLD WHO ARE SUFFERING FROM GLIOBLASTOMA OR HAVE BEEN AFFECTED BY THE DISEASE. THE ORGANIZATION PROVIDES A HUB FOR COMMUNICATION WHERE PEOPLE IN THE SAME SITUATION CAN SHARE THEIR EXPERIENCES.
    Expenses $849,667 · grants $189,316
  • SEE SCHEDULE O FOR DETAIL.THE ORGANIZATION HAS ESTABLISHED OVER 20 UNIQUE CAMPAIGNS, TO CONTINUE ITS ADVOCACY WORK, TO SHARE THE STORIES OF PATIENTS AND CAREGIVERS DEALING WITH BRAIN CANCER IN ONE WAY OR ANOTHER. THE GLIOBLASTOMA AKA GBM PODCAST, IN WHICH THE HOST HAS MEANINGFUL AND INSIGHTFUL CHATS WITHMEDICAL PROFESSIONALS, PATIENTS, CAREGIVERS, AND BIOTECH COMPANIES - TO FURTHER AWARENESS AND PROVIDE ANOTHER OUTLET FOR COMMUNITIES TO LEARN ABOUT BRAIN CANCER, IS NOW GOING INTO ITS THIRD SEASON WITH OVER 80,000 DOWNLOADS SINCE CREATION.
    Expenses $24,943

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
83-2388861
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2018
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$1,432,059
Income (IRS master file)
$1,804,767

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$1,804,767$1,112,732$1,432,059XML
990December 2024$1,025,244$807,776$728,675XML
990December 2023$832,005$480,261$492,941XML
990December 2022$281,490$260,309$134,493IRS
990-EZDecember 2021–––IRS
990-EZDecember 2020–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 83-2388861).

Questions about GLIOBLASTOMA RESEARCH ORGANIZATION INC

What is the EIN of GLIOBLASTOMA RESEARCH ORGANIZATION INC?
The employer identification number (EIN) of GLIOBLASTOMA RESEARCH ORGANIZATION INC is 83-2388861.
Is GLIOBLASTOMA RESEARCH ORGANIZATION INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2018.
Are donations to GLIOBLASTOMA RESEARCH ORGANIZATION INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does GLIOBLASTOMA RESEARCH ORGANIZATION INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of GLIOBLASTOMA RESEARCH ORGANIZATION INC due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did GLIOBLASTOMA RESEARCH ORGANIZATION INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of GLIOBLASTOMA RESEARCH ORGANIZATION INC?
The 990 for the year ended December 31, 2025 names AMBER BARBACH.
Who are the officers and directors of GLIOBLASTOMA RESEARCH ORGANIZATION INC?
The 990 for the year ended December 31, 2025 lists 6 people; 3 received compensation from the organization, the highest $108,429 (AMBER BARBACH, FOUNDER AND EXECUTIVE DIRECTOR).
How much revenue does GLIOBLASTOMA RESEARCH ORGANIZATION INC have?
On its 990 for the year ended December 31, 2025 it reported revenue of $1,804,767, expenses of $1,112,732 and total assets of $1,432,059 at year end.

Other nonprofits in MIAMI

All nonprofits in MIAMI · Florida · Philanthropy, voluntarism and grantmaking foundations